{"id":"W6968097576","doi":"10.5281/zenodo.15380122","title":"Perspectives and Insights on Antihemorrhagic Drugs: From Development to Submission of New Drug Submission (NDS) to Health Canada","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Scientific Innovation and Industrial Efficiency","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dosing; Clotting factor; Off-label use; Drug; Pharmacovigilance; Drug approval; Adverse effect; Drug development; Quality (philosophy)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001758905,0.0001287134,0.0002200693,0.0007568797,0.001531437,0.0005600419,0.00100769,0.00003775124,0.003218696],"category_scores_gemma":[0.003926383,0.0001057654,0.00002175153,0.002988328,0.00005704979,0.0001319861,0.0008066039,0.0001622194,0.0007523891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003696756,"about_ca_system_score_gemma":0.0002322264,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007867938,"about_ca_topic_score_gemma":0.0003864578,"domain_scores_codex":[0.9969441,0.0002953714,0.0005751282,0.0006719804,0.001247276,0.000266104],"domain_scores_gemma":[0.9978544,0.0001126479,0.0001661096,0.0004706546,0.0009958147,0.0004003527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009230541,0.00006582808,0.000005756887,0.000005025434,0.000006046639,0.000001579963,0.01776986,0.00007028683,0.001746909,0.00247709,0.6730153,0.304744],"study_design_scores_gemma":[0.0003829904,0.00009739351,0.002890744,0.00009055108,0.00000149433,0.000001542917,0.01245098,0.0001717874,0.005422179,0.0002754995,0.9780967,0.000118131],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9136901,0.0001149797,0.004008728,0.02270427,0.000616012,0.0007806218,0.00009413193,0.0001396261,0.05785156],"genre_scores_gemma":[0.9878634,0.00000659104,0.0007562861,0.001327589,0.0000454864,3.083851e-8,0.000101488,0.0001134056,0.009785705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3050814,"threshold_uncertainty_score":0.9997684,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08189828678990954,"score_gpt":0.3350733013520977,"score_spread":0.2531750145621882,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}